Detalhe da pesquisa
1.
Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemia.
Ann Hematol
; 94(8): 1357-61, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25911134
2.
High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma.
Blood
; 119(3): 687-91, 2012 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22128143
3.
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study.
Blood
; 120(8): 1589-96, 2012 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22791289
4.
Multiparameter flow cytometry evaluation of plasma cell DNA content and proliferation in 595 transplant-eligible patients with myeloma included in the Spanish GEM2000 and GEM2005<65y trials.
Am J Pathol
; 181(5): 1870-8, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22974582
5.
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance.
Blood
; 118(17): 4547-53, 2011 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21900193
6.
Erythrocytosis in a child due to Hb Andrew-Minneapolis [ß144(HC1)LysâAsn (AAG>AAT or AAC)] associated with a Spanish (δß)(0)-thalassemia.
Hemoglobin
; 37(1): 48-55, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23215953
7.
Association in cis of the mutations +20 (C>T) in the 5' untranslated region and IVS-II-745 (C>G) on the ß-globin gene.
Hemoglobin
; 37(2): 112-8, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23425204
8.
Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.
Blood
; 115(25): 5137-46, 2010 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-20393132
9.
Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease.
Haematologica
; 97(4): 616-21, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22058223
10.
Study of three families with Hb Agrinio [α29(B10)LeuâPro, CTG>CCG (α2)] in the Spanish population: three homozygous cases.
Hemoglobin
; 36(6): 526-32, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23094635
11.
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.
Blood
; 113(4): 775-83, 2009 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-18945964
12.
Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia.
Blood
; 114(1): 148-52, 2009 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-19398719
13.
Hb Extremadura [ß64(E8)GlyâSer;ß133(H11)ValâLeu]: a new molecular analysis.
Hemoglobin
; 35(4): 423-7, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21797709
14.
A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma.
Blood
; 112(9): 3591-3, 2008 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18612103
15.
Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: analysis of a series of 432 patients.
Blood
; 111(10): 5130-41, 2008 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18337555
16.
Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study.
Haematologica
; 95(11): 1913-20, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20663944
17.
Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients.
Haematologica
; 95(5): 745-51, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20133893
18.
Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.
Ann Hematol
; 89(11): 1073-80, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20526716
19.
BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML).
Ann Hematol
; 89(5): 453-8, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19943049
20.
Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis.
Haematologica
; 94(9): 1242-9, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19608685